Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRoc
Stefan Bernstein explains how the EU/Greenland critical raw materials partnership benefits GreenRocView Video
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investors
Utilico Insights - Jacqueline Broers assesses why Vietnam could be the darling of Asia for investorsView Video

Latest Share Chat

UDG Healthcare Raises Dividend As Full-Year Earnings Top Guidance

Tue, 24th Nov 2020 10:12

(Alliance News) - UDG Healthcare PLC on Tuesday said it beat full-year earnings per share guidance and lifted its payout.

Shares in UDG were up 4.7% at 785.00 pence in London on Tuesday.

Revenue for the financial year ended September 30 fell 1.4% to USD1.28 billion from USD1.30 billion the year before, though pretax profit climbed 46% to USD108.2 million.

The healthcare services provider took just USD9.4 million in net exceptional items before tax in the recently-ended year, down sharply from USD37.9 million the year before.

Adjusted diluted earnings per share amounted to 47.71 cents, versus 47.31 the year before, ahead of guidance of 43 cents to 45 cents announced in August.

"We are pleased to report a strong and resilient trading performance for FY20, which was ahead of our EPS guidance. This was driven by exceptionally strong growth in Sharp, in particular for serialised biotech and specialty packaging. Despite some parts of Ashfield being impacted by Covid-19, we adapted rapidly to support clients virtually and overall Ashfield performed in line with expectations," said Chief Executive Brendan McAtamney.

Ashfield division revenue fell 6% to USD891.5 million in the year, with adjusted operating profit falling 4% to USD105.2 million. Sharp division revenue, meanwhile, grew 11% to USD387.7 million, and operating profit rose 34% to US60.1 million.

Ashfield provides commercialisation services for the pharmaceutical and healthcare industry, while Sharp operates in the commercial packaging, clinical, manufacturing and technology services for the pharmaceutical and biotechnology industries.

UDG proposed a dividend of 17.00 cents per share, up 1.2% on the year before's 16.80 cents.

McAtamney said: "UDG Healthcare is a strong and well diversified business, underpinned by excellent long-term market fundamentals as evidenced by our strong financial performance in FY20. We have a robust financial position and will continue to leverage our investments in people, technology and infrastructure to remain well positioned for continued future growth."

By Lucy Heming; lucyheming@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

Related Shares

More News
16 Aug 2021 18:12

IN BRIEF: UDG Healthcare acquisition by CD&R completes

IN BRIEF: UDG Healthcare acquisition by CD&R completes

12 Aug 2021 19:25

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

TRADING UPDATES: Corcel buys Wo Wo Gap project; Amiad, UDG leave LSE

9 Aug 2021 09:32

UDG Healthcare takeover okayed by court but puts short stay on scheme

UDG Healthcare takeover okayed by court but puts short stay on scheme

29 Jul 2021 16:28

Thursday broker round-up

(Sharecast News) - Wizz Air: HSBC downgrades to 'reduce' and lowers target price from 4,500.0p to 4,100.0p; JP Morgan keeps at 'overweight' and marks ...

29 Jul 2021 10:36

BROKER RATINGS: Citi resumes Melrose at Buy; Peel cuts Pets At Home

BROKER RATINGS: Citi resumes Melrose at Buy; Peel cuts Pets At Home

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.